Category: Safety
-
Managing GLP-1 Side Effects: Nausea, Constipation and GI Tolerability
Gastrointestinal symptoms affect 40% to 70% of patients initiating GLP-1 receptor agonists. Here is the evidence on why these adverse effects occur, practical management strategies, and how to recognise rare, serious complications.
-
Isotretinoin (Roaccutane): Evidence, Safety, Teratogenicity and Monitoring
Isotretinoin remains the only disease-modifying, curative therapy for severe recalcitrant acne. We examine how it shrinks sebaceous glands by 90%, cumulative dose maths, monitoring protocols and safety.